In soft-tissue sarcomas, a distinct TLS profile characterized by active CD8+ T cells, PD-1 expression, and prominent B cell infiltration was associated with better clinical outcomes and identified a subgroup of patients who showed improved survival from PD-1 inhibitors [97]. The gene discussed is PDCD1; the disease is soft tissue sarcoma.